Open AccessAcnecutan in the treatment of severe forms of acne
Author(s) -
Д. К. Нажмутдинова,
T V Takha,
Ольга Игоревна Швец,
Д. К. Нажмутдинова,
T V Takha,
Ольга Игоревна Швец
Publication year - 2011
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/vdv1095
Subject(s) - acne , isotretinoin , bioavailability , medicine , oral administration , dermatology , drug , pharmacology
A new technology of production of oral isotretinoin, LIDOSE®, made it possible to increase its bioavailability by 20%,preserve high efficiency of the drug while reducing the quantity of isotretinoin to be taken orally by 20%, and, therefore,reduce both daily and course dose of the drug. The authors present the results of a study of clinical efficiency ofAcnecutan in treatment of patients suffering from medium to severe acne taking into account side effects. They also givedata on the administration of Acnecutan, which demonstrates the highest efficiency in treatment of this disease.